These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 29214451

  • 1. STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro.
    Aronova A, Min IM, Crowley MJP, Panjwani SJ, Finnerty BM, Scognamiglio T, Liu YF, Whitsett TG, Garg S, Demeure MJ, Elemento O, Zarnegar R, Fahey TJ.
    Ann Surg Oncol; 2018 Mar; 25(3):792-800. PubMed ID: 29214451
    [Abstract] [Full Text] [Related]

  • 2. Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours.
    Dos Santos Passaia B, Lima K, Kremer JL, da Conceição BB, de Paula Mariani BM, da Silva JCL, Zerbini MCN, Fragoso MCBV, Machado-Neto JA, Lotfi CFP.
    Invest New Drugs; 2020 Jun; 38(3):899-908. PubMed ID: 31441020
    [Abstract] [Full Text] [Related]

  • 3. Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.
    Altieri B, Sbiera S, Della Casa S, Weigand I, Wild V, Steinhauer S, Fadda G, Kocot A, Bekteshi M, Mambretti EM, Rosenwald A, Pontecorvi A, Fassnacht M, Ronchi CL.
    Oncotarget; 2017 Feb 07; 8(6):9323-9338. PubMed ID: 28030838
    [Abstract] [Full Text] [Related]

  • 4. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
    Rubin B, Regazzo D, Redaelli M, Mucignat C, Citton M, Iacobone M, Scaroni C, Betterle C, Mantero F, Fassina A, Pezzani R, Boscaro M.
    Tumour Biol; 2016 Oct 07; 37(10):13545-13555. PubMed ID: 27468715
    [Abstract] [Full Text] [Related]

  • 5. Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma.
    Poli G, Ruggiero C, Cantini G, Canu L, Baroni G, Armignacco R, Jouinot A, Santi R, Ercolino T, Ragazzon B, Assie G, Mannelli M, Nesi G, Lalli E, Luconi M.
    J Clin Endocrinol Metab; 2019 May 01; 104(5):1712-1724. PubMed ID: 30476173
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
    Wang S, Akhtar J, Wang Z.
    Tumour Biol; 2015 Sep 01; 36(10):7797-806. PubMed ID: 25944168
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of local injection of lentivirus-delivered stathmin1 and stathmin1 shRNA in human gastric cancer xenograft mouse.
    Akhtar J, Wang Z, Yu C, Zhang ZP.
    J Gastroenterol Hepatol; 2014 Sep 01; 29(9):1685-91. PubMed ID: 24720379
    [Abstract] [Full Text] [Related]

  • 9. Elevated STMN1 promotes tumor growth and invasion in endometrial carcinoma.
    He X, Liao Y, Lu W, Xu G, Tong H, Ke J, Wan X.
    Tumour Biol; 2016 Jul 01; 37(7):9951-8. PubMed ID: 26815505
    [Abstract] [Full Text] [Related]

  • 10. High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma.
    Bao P, Yokobori T, Altan B, Iijima M, Azuma Y, Onozato R, Yajima T, Watanabe A, Mogi A, Shimizu K, Nagashima T, Ohtaki Y, Obayashi K, Nakazawa S, Bai T, Kawabata-Iwakawa R, Asao T, Kaira K, Nishiyama M, Kuwano H.
    Ann Surg Oncol; 2017 Dec 01; 24(13):4017-4024. PubMed ID: 28933054
    [Abstract] [Full Text] [Related]

  • 11. Stathmin 1 is a potential novel oncogene in melanoma.
    Chen J, Abi-Daoud M, Wang A, Yang X, Zhang X, Feilotter HE, Tron VA.
    Oncogene; 2013 Mar 07; 32(10):1330-7. PubMed ID: 22665054
    [Abstract] [Full Text] [Related]

  • 12. BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy.
    Brown TC, Nicolson NG, Korah R, Carling T.
    J Am Coll Surg; 2018 Jun 07; 226(6):988-995. PubMed ID: 29428231
    [Abstract] [Full Text] [Related]

  • 13. Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.
    Liang R, Weigand I, Lippert J, Kircher S, Altieri B, Steinhauer S, Hantel C, Rost S, Rosenwald A, Kroiss M, Fassnacht M, Sbiera S, Ronchi CL.
    Front Endocrinol (Lausanne); 2020 Jun 07; 11():219. PubMed ID: 32373071
    [Abstract] [Full Text] [Related]

  • 14. SLC12A7 alters adrenocortical carcinoma cell adhesion properties to promote an aggressive invasive behavior.
    Brown TC, Murtha TD, Rubinstein JC, Korah R, Carling T.
    Cell Commun Signal; 2018 Jun 08; 16(1):27. PubMed ID: 29884238
    [Abstract] [Full Text] [Related]

  • 15. LncRNA HOTAIR participates in the development and progression of adrenocortical carcinoma via regulating cell cycle.
    Yan ZC, He L, Qiu JH, Deng WT, Lu JR, Yuan Z, Liu DJ, Zheng RQ, Jiang W.
    Eur Rev Med Pharmacol Sci; 2018 Oct 08; 22(20):6640-6649. PubMed ID: 30402836
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Survivin in adrenocortical tumors - pathophysiological implications and therapeutic potential.
    Sbiera S, Kroiss M, Thamm T, Beyer M, Majidi F, Kuehner D, Wobser M, Becker JC, Adam P, Ronchi C, Allolio B, Fassnacht M.
    Horm Metab Res; 2013 Feb 08; 45(2):137-46. PubMed ID: 23143666
    [Abstract] [Full Text] [Related]

  • 18. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
    Chen YL, Uen YH, Li CF, Horng KC, Chen LR, Wu WR, Tseng HY, Huang HY, Wu LC, Shiue YL.
    Ann Surg Oncol; 2013 Nov 08; 20(12):4041-54. PubMed ID: 22911364
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of Stathmin 1 correlates with poor prognosis and promotes cell migration and proliferation in oesophageal squamous cell carcinoma.
    Ni PZ, He JZ, Wu ZY, Ji X, Chen LQ, Xu XE, Liao LD, Wu JY, Li EM, Xu LY.
    Oncol Rep; 2017 Dec 08; 38(6):3608-3618. PubMed ID: 29039594
    [Abstract] [Full Text] [Related]

  • 20. Feminizing Adrenocortical Carcinoma: The Source of Estrogen Production and the Role of Adrenal-Gonadal Dedifferentiation.
    Wu L, Xie J, Jiang L, Su T, Ye L, Zhou W, Jiang Y, Zhang C, Ning G, Wang W.
    J Clin Endocrinol Metab; 2018 Oct 01; 103(10):3706-3713. PubMed ID: 30053001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.